Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065529Phase 4Not yet recruiting
Phase 4, randomised, open-label trial comparing remimazolam with propofol (2 arms). Primary endpoint: Area under the baseline mean arterial pressure over the first 15 minutes after induction. Planned start Nov 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065529.